Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 色谱法 化学
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
风中可仁完成签到 ,获得积分10
1秒前
笨笨千亦完成签到 ,获得积分10
3秒前
6秒前
落后的小伙完成签到,获得积分10
6秒前
7秒前
Bin_Liu发布了新的文献求助10
12秒前
14秒前
小小马发布了新的文献求助10
14秒前
sa0022完成签到,获得积分10
16秒前
lym完成签到,获得积分10
17秒前
这个研究生不读也罢完成签到,获得积分10
18秒前
蕉鲁诺蕉巴纳完成签到,获得积分0
19秒前
独特的凝云完成签到 ,获得积分0
20秒前
Silent完成签到,获得积分10
20秒前
bobzhang2026完成签到,获得积分10
22秒前
手帕很忙完成签到,获得积分10
26秒前
Echo1128完成签到 ,获得积分10
26秒前
Daria完成签到 ,获得积分10
26秒前
ThewhY完成签到,获得积分20
33秒前
34秒前
浅蓝色的盛夏完成签到 ,获得积分10
34秒前
甜美的桐完成签到,获得积分10
37秒前
sonicker完成签到 ,获得积分10
37秒前
38秒前
simongao完成签到 ,获得积分10
38秒前
beizi完成签到,获得积分10
38秒前
ThewhY发布了新的文献求助30
39秒前
heyseere完成签到,获得积分10
43秒前
july7292完成签到,获得积分10
44秒前
缥缈的闭月完成签到,获得积分10
47秒前
hkkogcu7449oi完成签到,获得积分10
48秒前
天天快乐应助ThewhY采纳,获得10
49秒前
Ava应助patty采纳,获得10
49秒前
dashi完成签到,获得积分10
50秒前
小二郎应助arniu2008采纳,获得10
51秒前
独步天下完成签到,获得积分10
51秒前
Keyuuu30完成签到,获得积分0
55秒前
yes完成签到 ,获得积分10
56秒前
58秒前
龙2024完成签到,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Developing Genetic Editing Tools for Lysobacter 2000
卤化钙钛矿人工突触的研究 2000
Моделирование процессов самоорганизации в кристаллообразующих системах 1000
History of U.S. Space Surveillance and Satellite Cataloging 1000
Malcolm Fraser : a biography 700
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6515710
求助须知:如何正确求助?哪些是违规求助? 8308720
关于积分的说明 17757565
捐赠科研通 5617688
什么是DOI,文献DOI怎么找? 2925117
邀请新用户注册赠送积分活动 1902093
关于科研通互助平台的介绍 1763468